PRO35 ANALYZING THE LEVEL OF EVIDENCE REQUIRED FOR ONCOLOGY VERSUS NON-ONCOLOGY ORPHAN DRUGS AS IT RELATES TO PRICE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2365
https://www.valueinhealthjournal.com/article/S1098-3015(19)34743-6/fulltext
Title :
PRO35 ANALYZING THE LEVEL OF EVIDENCE REQUIRED FOR ONCOLOGY VERSUS NON-ONCOLOGY ORPHAN DRUGS AS IT RELATES TO PRICE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34743-6&doi=10.1016/j.jval.2019.09.2365
First page :
Section Title :
Open access? :
No
Section Order :
12067